A case of proteasome-associated auto-inflammatory syndrome with compound heterozygous mutations
A McDermott, AA Jesus, Y Liu, P Kim, J Jacks… - Journal of the American …, 2013 - jaad.org
2. Sinha R, Edmonds K, Newton-Bishop JA, Gore ME, Larkin J, Fearfield L. Cutaneous
adverse events associated with vemurafenib in patients with metastatic melanoma: practical
advice on diagnosis, prevention and management of the main treatment-related skin
toxicities. Br J Dermatol 2012; 167: 987-94. 3. Huang V, Hepper D, Anadkat M, Cornelius L.
Cutaneous toxic effects associated with vemurafenib and inhibition of the BRAF pathway.
Arch Dermatol 2012; 148: 628-33. 4. Maio M. Melanoma as a model tumour for immuno …
adverse events associated with vemurafenib in patients with metastatic melanoma: practical
advice on diagnosis, prevention and management of the main treatment-related skin
toxicities. Br J Dermatol 2012; 167: 987-94. 3. Huang V, Hepper D, Anadkat M, Cornelius L.
Cutaneous toxic effects associated with vemurafenib and inhibition of the BRAF pathway.
Arch Dermatol 2012; 148: 628-33. 4. Maio M. Melanoma as a model tumour for immuno …